Bruce Camitta

1.1k total citations
17 papers, 645 citations indexed

About

Bruce Camitta is a scholar working on Public Health, Environmental and Occupational Health, Hematology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Bruce Camitta has authored 17 papers receiving a total of 645 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Public Health, Environmental and Occupational Health, 8 papers in Hematology and 5 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Bruce Camitta's work include Acute Lymphoblastic Leukemia research (11 papers), Acute Myeloid Leukemia Research (7 papers) and Childhood Cancer Survivors' Quality of Life (4 papers). Bruce Camitta is often cited by papers focused on Acute Lymphoblastic Leukemia research (11 papers), Acute Myeloid Leukemia Research (7 papers) and Childhood Cancer Survivors' Quality of Life (4 papers). Bruce Camitta collaborates with scholars based in United States, United Kingdom and Cambodia. Bruce Camitta's co-authors include C. Philip Steuber, Andrew M. Yeager, Andrew J. Carroll, Susumu Inoue, Yaddanapudi Ravindranath, Myron Chang, John Graham‐Pole, Howard J. Weinstein, Jeffrey P. Krischer and Nyla A. Heerema and has published in prestigious journals such as New England Journal of Medicine, Blood and Cancer.

In The Last Decade

Bruce Camitta

16 papers receiving 622 citations

Peers

Bruce Camitta

PHEOH

HEMAT

PPCH

ONCOL

Myriam Campbell Chile

Laura Burden United States

Ulrika Norén‐Nyström Sweden

Concepción Bethencourt Spain

José Sancho Spain

W.M. Crist United States

U. Creutzig Germany

Ching-Hon Pui United States

Maya Mahmoud United States

Regina Reutzel Germany

Myriam Campbell Chile

Bruce Camitta

443 ×0.9

PHEOH

287 ×0.6

HEMAT

301 ×1.4

PPCH

114 ×1.0

ONCOL

64 ×0.7

Citations per year, relative to Bruce Camitta Bruce Camitta (= 1×) peers Myriam Campbell

Countries citing papers authored by Bruce Camitta

Since Specialization

Citations

This map shows the geographic impact of Bruce Camitta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bruce Camitta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bruce Camitta more than expected).

Fields of papers citing papers by Bruce Camitta

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bruce Camitta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bruce Camitta. The network helps show where Bruce Camitta may publish in the future.

Co-authorship network of co-authors of Bruce Camitta

This figure shows the co-authorship network connecting the top 25 collaborators of Bruce Camitta. A scholar is included among the top collaborators of Bruce Camitta based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bruce Camitta. Bruce Camitta is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Miliya, Thyl, Arjun Chandna, Jason A. Jarzembowski, et al.. (2022). Case Report: The First Case Report of Visceral Leishmaniasis in Cambodia. American Journal of Tropical Medicine and Hygiene. 107(2). 336–338. 2 indexed citations

Qaddoumi, Ibrahim, et al.. (2021). Indirect Effects of COVID on Oncology Patients. Journal of Pediatric Hematology/Oncology. 43(8). 314–315.

Kelly, Katherine Patterson, et al.. (2013). Caregiving Demands and Well-being in Parents of Children Treated With Outpatient or Inpatient Methotrexate Infusion. Journal of Pediatric Hematology/Oncology. 36(6). 495–500. 15 indexed citations

Oliansky, Denise M, Bruce Camitta, Paul S. Gaynon, et al.. (2012). The Role of Cytotoxic Therapy with Hematopoietic Stem Cell Transplantation in the Treatment of Pediatric Acute Lymphoblastic Leukemia: Update of the 2005 Evidence-Based Review. Biology of Blood and Marrow Transplantation. 18(7). 979–981. 34 indexed citations

Gaynon, Paul S., Bruce Camitta, Yousif Matloub, et al.. (2007). Outcomes for B-Precursor Patients in Legacy Children’s Cancer Group (CCG) and Pediatric Oncology Group (POG) Studies in Childhood Acute Lymphoblastic Leukemia (ALL): A Children’s Oncology Group (COG) Report.. Blood. 110(11). 847–847. 1 indexed citations

Nachman, James B., Nyla A. Heerema, Harland N. Sather, et al.. (2007). Outcome of treatment in children with hypodiploid acute lymphoblastic leukemia. Blood. 110(4). 1112–1115. 164 indexed citations

Raetz, Elizabeth A., Michael J. Borowitz, Meenakshi Devidas, et al.. (2006). Outcomes of Children with First Marrow Relapse: Results from Children’s Oncology Group (COG) Study AALL01P2.. Blood. 108(11). 1871–1871. 5 indexed citations

Winick, Naomi, Michael J. Borowitz, Paul L. Martin, et al.. (2006). Changes in the Delivery of Standard Chemotherapeutic Agents during Induction Affect Early Measures of Minimal Residual Disease (MRD): POG 9900 for Patients with B-Precursor Low and Standard Risk ALL.. Blood. 108(11). 2272–2272. 3 indexed citations

Borowitz, Michael J., Meenakshi Devidas, W. Paul Bowman, et al.. (2006). Prognostic Significance of Minimal Residual Disease (MRD) in Childhood B-Precursor ALL and Its Relation to Other Risk Factors. A Children’s Oncology Group (COG) Study.. Blood. 108(11). 219–219. 7 indexed citations

10.

Dunsmore, Kimberly P., Meenakshi Devidas, Michael J. Borowitz, et al.. (2006). Nelarabine Can Be Safely Incorporated into an Intensive, Multiagent Chemotherapy Regimen for the Treatment of T-Cell Acute Lymphocytic Leukemia (ALL) in Children: A Report of the Children’s Oncology Group (COG) AALL00P2 Protocol for T-Cell Leukemia.. Blood. 108(11). 1864–1864. 3 indexed citations

11.

Borowitz, Michael J., DJ Pullen, Naomi Winick, et al.. (2005). Comparison of diagnostic and relapse flow cytometry phenotypes in childhood acute lymphoblastic leukemia: Implications for residual disease detection: A report from the children's oncology group. Cytometry Part B Clinical Cytometry. 68B(1). 18–24. 70 indexed citations

12.

Borowitz, Michael J., Meenakshi Devidas, W. Paul Bowman, et al.. (2005). Prognostic Significance of Minimal Residual Disease (MRD) in Children with High Risk Acute Lymphoblastic Leukemia(ALL) A Children’s Oncology Group Study.. Blood. 106(11). 85–85. 5 indexed citations

13.

Matloub, Yousif, Barbara L. Asselin, Linda C. Stork, et al.. (2004). Outcome of Children with T-Cell Acute Lymphoblastic Leukemia (T-ALL) and Standard Risk (SR) Features: Results of CCG-1952, CCG-1991 and POG 9404.. Blood. 104(11). 680–680. 4 indexed citations

14.

Ravindranath, Yaddanapudi, Andrew M. Yeager, Myron Chang, et al.. (1996). Autologous Bone Marrow Transplantation versus Intensive Consolidation Chemotherapy for Acute Myeloid Leukemia in Childhood. New England Journal of Medicine. 334(22). 1428–1434. 185 indexed citations

15.

Tebbi, Cameron K., Jeffrey Krischer, Donald J. Fernbach, et al.. (1990). Toxicity of high-dose cytosine arabinoside in the treatment of advanced childhood tumors resistant to conventional therapy a pediatric oncology group study. Cancer. 66(10). 2064–2067. 4 indexed citations

16.

Mulhern, Raymond K., Larry E. Kun, Stephen J. Lauer, et al.. (1990). Treatment of Meningeal Relapse in Childhood Acute Lymphoblastic Leukemia. Journal of Pediatric Hematology/Oncology. 12(1). 45–50. 24 indexed citations

17.

Rivera, Gaston K., George R. Buchanan, James M. Boyett, et al.. (1986). Intensive Retreatment of Childhood Acute Lymphoblastic Leukemia in First Bone Marrow Relapse. New England Journal of Medicine. 315(5). 273–278. 119 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact